Minrin (Desmopressin Acetate)

Desmopressin, the active ingredient in Minrin, is a synthetic vasopressin analog presented as a nasal formulation for intranasal use. It acts as an antidiuretic agent and is indicated for central diabetes insipidus, nocturnal enuresis in children, and bleeding disorders such as von Willebrand disease and mild hemophilia A.

GNH USA supplies Minrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality compliance with EU standards and provides reliable global logistics.

Desmopressin acts on the antidiuretic hormone pathway to manage disorders of water balance and hemostasis.

- Central diabetes insipidus: reduces excessive urine output and normalizes plasma osmolality. - Nocturnal enuresis: decreases nighttime bladder emptying episodes in children. - Von Willebrand disease: enhances plasma von Willebrand factor levels to improve clotting. - Mild hemophilia A: raises factor VIII activity to aid hemostasis.

Desmopressin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or congestion - Headache - Mild hyponatremia - Thirst - Nausea - Dry mouth

Serious or Rare Side Effects: - Severe hyponatremia leading to seizures or coma - Water intoxication with cerebral edema - Allergic reactions including rash or anaphylaxis - Thromboembolic events (rare) - Hypertension due to fluid overload

Use of Desmopressin requires careful monitoring and patient education to minimise risks.

- Renal function: assess serum sodium and fluid balance before and during therapy. - Elderly patients: increased susceptibility to hyponatremia; monitor closely. - Concomitant diuretics: adjust fluid intake to avoid excessive water loss. - History of hyponatremia: avoid or use the lowest effective dose. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at room temperature: keep in the original container, protect from moisture and light.

Desmopressin can interact with several medicines that affect water balance or hemostasis.

Major Interactions (Avoid): - Carbamazepine: may reduce desmopressin efficacy by increasing hepatic metabolism. - Thiazide diuretics: combined use can precipitate severe hyponatremia. - NSAIDs: may potentiate antidiuretic effect and increase risk of fluid retention.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: monitor blood pressure as fluid shifts may occur. - Other antidiuretic agents (e.g., oxytocin): monitor for excessive water retention. - Estrogen therapy: may increase risk of hyponatremia; observe serum electrolytes.